• Home
  • About Us
  • Advisory board
  • Neurology
    • Alzheimer’s Disease
    • Epilepsy
    • Headache/Migraine
    • Movement Disorders
    • Multiple Sclerosis
    • Neuro-Oncology
    • Neuroradiology
    • Neurosurgery
    • Pain
    • Stroke
    • All Articles
    • All Videos
  • Psychiatry
    • Addiction
    • ADHD
    • Anxiety
    • Bipolar Disorder
    • Depression
    • Obesity
    • OCD
    • Psychosis
    • Schizophrenia
    • Sleep Disorders
    • All Articles
    • All Videos
  • CNS Journal
  • CME
  • Podcasts
    • All Podcasts
    • Navigating the PD universe
    • Reflections on Parkinson’s Disease
    • Parkinson Weekly
All Acute Antimigraine Drugs Protect Against Chronic Migraine

All Acute Antimigraine Drugs Protect Against Chronic Migraine

by Ket Patel | Oct 23, 2012 | All Articles For Neurology, Headache/Migraine

The use of any form of acute antimigraine medication by patients with episodic migraine – be it single analgesics, combination analgesics, or triptans – exerted a protective effect against developing chronic migraine in a large, prospective, population-based study....
Can Lapatinib Prevent Brain Metastases From Breast Cancer? Data ‘Inconclusive’

Can Lapatinib Prevent Brain Metastases From Breast Cancer? Data ‘Inconclusive’

by Ket Patel | Oct 22, 2012 | All Articles For Neurology, Neuro-Oncology

Mixed results in phase II and III clinical trials leave open the question of whether lapatinib can prevent brain metastases in women with HER2-positive breast cancer. Lapatinib (Tykerb) did not decrease the development of brain metastases when compared with...
All Acute Antimigraine Drugs Protect Against Chronic Migraine

Ahead Of The Journals: Discontinuing Risperidone In AD

by Ket Patel | Oct 22, 2012 | All Articles For Neurology, Alzheimer's Disease

          The medical illustration is provided courtesy of Alzheimer’s Disease Research, a program of BrightFocus Foundation. Among patients with Alzheimer’s disease who develop psychosis or agitation-aggression that responds to...

Cognitive Rehabilitation In Parkinson’s Disease: Evidence From Neuroimaging

Alzheimer’s Imaging Agent Considered For Medicare Coverage

Alzheimer’s Imaging Agent Considered For Medicare Coverage

by Ket Patel | Oct 15, 2012 | All Articles For Neurology, Alzheimer's Disease, Latest Articles

The imaging agent florbetapir F 18 injection (Amyvid), used to exclude a diagnosis of Alzheimer’s disease, is being evaluated for Medicare reimbursement, the Centers for Medicare and Medicaid Services has announced. The agency stated on Oct. 9 that it expected a...
Page 123 of 168««...102030...122123124...130140150...»»

Follow Us

  • Follow
  • Follow
  • Follow
  • Follow

Newsletter

Keep up to date with our latest
articles and journals

Subscribe

Oruen is the leading CNS medical publication and audio-visual platform committed to improving international communication and medical education for physicians with clinical interests in CNS medicine.

Navigation
  • Home
  • About Us
  • Advisory Board
  • CNS Journal
  • CME
  • Contact Us
Contact Oruen

Name: Dr. James Coe  (MD, PhD)

Editor

E-mail: Editor@oruen.com

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2026. Oruen LTD. All Rights Reserved. | Terms & Conditions | Privacy Policy | Sitemap

We use cookies to ensure that we give you the best experience on our website, please read our Privacy Policy before using this website.